enkephalin, leucine has been researched along with dynorphin (1-17) in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (50.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cassel, JA; Chung, NN; Daubert, JD; DeHaven, RN; Goodman, M; Schiller, PW; Schlechtingen, G; Taulane, JP | 1 |
| Miller, L; Rance, MJ; Shaw, JS; Traynor, JR | 1 |
| Akita, K; Hatanaka, H; Maruyama, M; Sugino, H | 1 |
| Adapa, ID; Auh, JS; Berzetei-Gurske, IP; Brandt, SR; Craymer, K; Farrington, L; Haggart, D; Kennedy, JM; O'Brien, A; Polgar, WE; Rodriguez, L; Schwartz, RW; Toll, L; White, A | 1 |
4 other study(ies) available for enkephalin, leucine and dynorphin (1-17)
| Article | Year |
|---|---|
Structure-activity relationships of dynorphin a analogues modified in the address sequence.
Topics: Analgesics, Opioid; Animals; CHO Cells; Cricetinae; Dynorphins; Guanosine 5'-O-(3-Thiotriphosphate); Guinea Pigs; Ileum; In Vitro Techniques; Muscle Contraction; Muscle, Smooth; Oligopeptides; Radioligand Assay; Receptors, Opioid, delta; Receptors, Opioid, kappa; Receptors, Opioid, mu; Structure-Activity Relationship | 2003 |
Conversion of dynorphin-(1-9) to [Leu5]enkephalin by the mouse vas deferens in vitro.
Topics: Animals; Benzomorphans; Chromatography, High Pressure Liquid; Dynorphins; Enkephalin, Leucine; In Vitro Techniques; Male; Mice; Muscle, Smooth; Narcotic Antagonists; Peptide Fragments; Vas Deferens | 1985 |
Binding characteristics of [3H]opioid ligands to active opioid binding sites solubilized from rat brain membranes by glycodeoxycholate and NaCl: the recovery of binding activity by dilution.
Topics: Animals; Brain; Dynorphins; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Enkephalin, Methionine; Enkephalins; Glycodeoxycholic Acid; Male; Naloxone; Peptide Fragments; Rats; Rats, Inbred Strains; Receptors, Opioid; Sodium Chloride; Solutions | 1987 |
Standard binding and functional assays related to medications development division testing for potential cocaine and opiate narcotic treatment medications.
Topics: Animals; Aorta, Thoracic; Cocaine; Cyclic AMP; Electric Stimulation; Guinea Pigs; Humans; Ileum; In Vitro Techniques; Male; Mice; Muscle, Smooth; Opioid-Related Disorders; Rats; Receptors, Dopamine; Receptors, Opioid; Receptors, Serotonin; Substance-Related Disorders | 1998 |